Evidence map›Paper›PMID 20715850›Full record

ArticleBioconjugate chemistry2010

GABAC receptor binding of quantum-dot conjugates of variable ligand valency.

Hélène A Gussin, Ian D Tomlinson, Niraj J Muni, Deborah M Little, Haohua Qian, Sandra J Rosenthal, David R Pepperberg

Open access · greenAbstract read
In one paragraph

Article in Bioconjugate chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Labeling of neuronal receptors and transporters with quantum dots.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hélène A GussinDepartments of Ophthalmology and Visual Sciences, Bioengineering, Neurology and Rehabilitation, University of Illinois at Chicago, 1855 W. Taylor St., Chicago, IL 60612, USA.
Ian D Tomlinson
Niraj J Muni
Deborah M Little
Haohua Qian
Sandra J Rosenthal
David R Pepperberg
Vanderbilt University · USUniversity of Illinois Chicago · US

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MCANANY, JAMES JASON · 1985 to 2025
$14.8M
Development of Nanoscale Neuromodulating PlatformsR01EY016094 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PEPPERBERG, DAVID R · 2006 to 2010
$6.7M
Quantum Dot Nanoconjugate Imaging of Neural ReceptorsR01EB003728 · NIBIB · VANDERBILT UNIVERSITY · PI ROSENTHAL, SANDRA JEAN · 2004 to 2010
$2.1M
The Role of Feedback to Facilitate Category LearningR03MH075791 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LITTLE, DEBORAH MARLEEN · 2005 to 2005
$76k
NEI NIH HHS EY01792NEI NIH HHS EY16094NEI NIH HHS P30 EY001792NEI NIH HHS R01 EY016094NIBIB NIH HHS EB003728NIBIB NIH HHS R01 EB003728NIMH NIH HHS MH075791NIMH NIH HHS R03 MH075791PHS HHS EM72048
6 · The paper itself

Abstract

Highly fluorescent CdSe quantum dots (qdots) can serve as a platform for tethering multiple copies of a receptor-targeted ligand, affording study of how the level of multivalency affects receptor binding. We previously showed that qdots conjugated with long PEG chains terminated by muscimol, a known GABA(C) agonist, exhibit specific binding to the surface membrane of GABA(C) receptor-expressing Xenopus oocytes. The present report addresses the effect of varying the number, i.e., valency, of muscimol- (M-) terminated PEG chains attached to the qdot on binding of the resulting conjugate to GABA(C) receptors. M-PEG-qdots of differing muscimol valency were prepared by conjugating AMP-CdSe/ZnS qdots with muscimol-terminated and methylamine-terminated PEG chains in proportions designed to yield varying percentages of muscimol-terminated chains among the total approximately 150-200 chains bound to the qdot. The investigated valencies represented 0%, approximately 25%, approximately 50%, and 100% loading with muscimol (preparations termed M-PEG-qdot0, M-PEG-qdot25, M-PEG-qdot50, and M-PEG-qdot100, respectively. Binding of a given conjugate to surface membranes of GABA(C) receptor-expressing oocytes was analyzed by quantitative fluorescence microscopy following defined incubation with approximately 30 nM of the conjugate. With 5-20 min incubation, the fluorescence signal resulting from incubation with M-PEG-qdot25 exceeded, by approximately 6-fold, the fluorescence level obtained with M-PEG-qdot preparations that lacked muscimol-terminated chains (M-PEG-qdot0). M-PEG-qdot50 yielded a net signal roughly similar to that of M-PEG-qdot25, and that produced by M-PEG-qdot100 exceeded, by approximately 30-50%, those for M-PEG-qdot25 and M-PEG-qdot50. The time course of changes in oocyte surface membrane fluorescence resulting from the introduction of and removal of M-PEG-qdots in the medium bathing the oocyte indicated only a modest dependence of both binding and wash-out kinetics on muscimol valency. The results demonstrate a dependence of the binding activity of the M-PEG-qdot conjugates on muscimol valency, presumably reflecting higher GABA(C) avidity and/or affinity of the muscimol at high valency, and provide insight on the interactions of membrane receptor proteins with qdot conjugates containing multiple copies of a receptor-targeting ligand.

Indexed as

Quantum DotsBinding SitesCadmium CompoundsFluorescenceLigandsMethylaminesMolecular StructureMuscimolPolyethylene GlycolsReceptors, GABASelenium CompoundsSulfidesZinc CompoundsCadmium Compoundscadmium selenideGABA-C receptorLigandsmethylamineMethylaminesMuscimolPolyethylene GlycolsReceptors, GABASelenium CompoundsSulfidesZinc Compoundszinc sulfide

Identifiers

PMID20715850
PMCPMC2929923
OpenAlexW1972314634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.